Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and HTLV-II Infections

tetradecanoylphorbol acetate has been researched along with HTLV-II Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buckner, C; Hooper, WC; Lal, RB; Pardi, D; Rudolph, D1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and HTLV-II Infections

ArticleYear
Infection with human T-lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and interleukin-6.
    Blood, 1993, Apr-01, Volume: 81, Issue:7

    Topics: Cell Line; Deltaretrovirus Infections; Growth Inhibitors; HTLV-I Infections; HTLV-II Infections; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Tetradecanoylphorbol Acetate

1993